Get startedLog in
    Picture of Duality Biotherapeutics logo

    9606 — Duality Biotherapeutics Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Duality Biotherapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSARS
    Standards:
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinal
    Net Income/Starting Line-202-1,015-2,595
    Depreciation
    Amortisation
    Non-Cash Items9881,0382,296
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital25.4254481
    Change in Accounts Receivable
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities816286195
    Capital Expenditures-35.9-31.2-13.7
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-42.6-180-1,899
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-78.5-211-1,913
    Financing Cash Flow Items-1.59-4.22-84.6
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities10.8-7.621,809
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash7557867.5